Back to Gene
CTDP1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

CTDP1 gene

The CTDP1 gene provides instructions for making a protein that regulates RNA polymerase II, a key enzyme in the process of gene transcription.

Normal Function

The CTDP1 gene provides instructions for making a protein called carboxy-terminal domain phosphatase 1. This protein helps regulate the activity of an enzyme called RNA polymerase II. The RNA polymerase II enzyme initiates transcription, which is a key step in using the information carried by genes to direct the production (synthesis) of proteins.

Health Conditions Related to Genetic Changes

Congenital cataracts, facial dysmorphism, and neuropathy

Thus far, everyone with CCFDN has had the same mutation in both copies of the CTDP1 gene in each cell. This mutation, written as IVS6+389C>T, alters the way the gene's instructions are pieced together to produce the carboxy-terminal domain phosphatase 1 protein. The altered instructions introduce a premature stop signal, resulting in an abnormally short, nonfunctional protein that cannot regulate transcription. Defective regulation of the transcription process affects the development and function of many parts of the body. It is not known how nonfunctional carboxy-terminal domain phosphatase 1 protein results in the specific signs and symptoms of CCFDN.

Other Names for This Gene

  • CCFDN
  • CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1
  • CTD of POLR2A, phosphatase of, subunit 1
  • CTDP1_HUMAN
  • FCP1
  • RNA polymerase II subunit A C-terminal domain phosphatase
  • RNA polymerase II subunit A C-terminal domain phosphatase isoform FCP1a
  • RNA polymerase II subunit A C-terminal domain phosphatase isoform FCP1b
  • serine phosphatase FCP1a
  • TFIIF-associating CTD phosphatase 1
  • transcription factor IIF-associating CTD phosphatase 1

Genomic Location

The CTDP1 gene is found on chromosome 18.

Frequently Asked Questions

CCFDN is a genetic disorder characterized by congenital cataracts (clouding of the eye lens present at birth), distinctive facial features, and nerve damage (neuropathy). It is caused by a specific mutation in both copies of the CTDP1 gene, which leads to a nonfunctional protein that disrupts the process of gene transcription.
The main signs and symptoms of CCFDN include cataracts present from birth, specific facial characteristics (facial dysmorphism), and neuropathy, which can affect nerve function throughout the body.
CCFDN is inherited in an autosomal recessive pattern. This means a person must inherit a mutated copy of the CTDP1 gene from both parents to develop the condition. Parents who each carry one copy of the mutated gene typically do not show symptoms but can pass the mutation to their children.
Yes, the specific mutation, written as IVS6+389C>T, which is found in all individuals diagnosed with CCFDN, can be identified through genetic testing.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab